BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 12391153)

  • 41. Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer.
    Viglietto G; Motti ML; Bruni P; Melillo RM; D'Alessio A; Califano D; Vinci F; Chiappetta G; Tsichlis P; Bellacosa A; Fusco A; Santoro M
    Nat Med; 2002 Oct; 8(10):1136-44. PubMed ID: 12244303
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein.
    Zhu X; Ohtsubo M; Böhmer RM; Roberts JM; Assoian RK
    J Cell Biol; 1996 Apr; 133(2):391-403. PubMed ID: 8609171
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cooperative regulation of the cell division cycle by the protein kinases RAF and AKT.
    Mirza AM; Gysin S; Malek N; Nakayama K; Roberts JM; McMahon M
    Mol Cell Biol; 2004 Dec; 24(24):10868-81. PubMed ID: 15572689
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1).
    Cheng M; Sexl V; Sherr CJ; Roussel MF
    Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1091-6. PubMed ID: 9448290
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of cyclin D3-cdk4 complexes in fibroblasts expressing and lacking p27(kip1) and p21(cip1).
    Bagui TK; Jackson RJ; Agrawal D; Pledger WJ
    Mol Cell Biol; 2000 Dec; 20(23):8748-57. PubMed ID: 11073976
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cyclin D3-associated kinase activity is regulated by p27kip1 in BALB/c 3T3 cells.
    Dong F; Agrawal D; Bagui T; Pledger WJ
    Mol Biol Cell; 1998 Aug; 9(8):2081-92. PubMed ID: 9693368
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
    Li A; Wang J; Wu M; Zhang X; Zhang H
    Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
    [TBL] [Abstract][Full Text] [Related]  

  • 48. BCR/ABL regulates expression of the cyclin-dependent kinase inhibitor p27Kip1 through the phosphatidylinositol 3-Kinase/AKT pathway.
    Gesbert F; Sellers WR; Signoretti S; Loda M; Griffin JD
    J Biol Chem; 2000 Dec; 275(50):39223-30. PubMed ID: 11010972
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Retinoic acid-mediated G1 arrest is associated with induction of p27(Kip1) and inhibition of cyclin-dependent kinase 3 in human lung squamous carcinoma CH27 cells.
    Hsu SL; Hsu JW; Liu MC; Chen LY; Chang CD
    Exp Cell Res; 2000 Aug; 258(2):322-31. PubMed ID: 10896783
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells.
    Pan MH; Chen WJ; Lin-Shiau SY; Ho CT; Lin JK
    Carcinogenesis; 2002 Oct; 23(10):1677-84. PubMed ID: 12376477
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells.
    Appleman LJ; van Puijenbroek AA; Shu KM; Nadler LM; Boussiotis VA
    J Immunol; 2002 Mar; 168(6):2729-36. PubMed ID: 11884439
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression.
    Liang J; Slingerland JM
    Cell Cycle; 2003; 2(4):339-45. PubMed ID: 12851486
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of Hsp90 function by ansamycins causes retinoblastoma gene product-dependent G1 arrest.
    Srethapakdi M; Liu F; Tavorath R; Rosen N
    Cancer Res; 2000 Jul; 60(14):3940-6. PubMed ID: 10919672
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular mechanism of cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I.
    Iwanaga R; Ohtani K; Hayashi T; Nakamura M
    Oncogene; 2001 Apr; 20(17):2055-67. PubMed ID: 11360190
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanisms of cyclin-dependent kinase inactivation by progestins.
    Musgrove EA; Swarbrick A; Lee CS; Cornish AL; Sutherland RL
    Mol Cell Biol; 1998 Apr; 18(4):1812-25. PubMed ID: 9528753
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.
    Koga H; Sakisaka S; Harada M; Takagi T; Hanada S; Taniguchi E; Kawaguchi T; Sasatomi K; Kimura R; Hashimoto O; Ueno T; Yano H; Kojiro M; Sata M
    Hepatology; 2001 May; 33(5):1087-97. PubMed ID: 11343236
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27.
    Decker T; Schneller F; Hipp S; Miething C; Jahn T; Duyster J; Peschel C
    Leukemia; 2002 Mar; 16(3):327-34. PubMed ID: 11896535
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb.
    Ezhevsky SA; Nagahara H; Vocero-Akbani AM; Gius DR; Wei MC; Dowdy SF
    Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10699-704. PubMed ID: 9380698
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Induced expression of p16(INK4a) inhibits both CDK4- and CDK2-associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes.
    McConnell BB; Gregory FJ; Stott FJ; Hara E; Peters G
    Mol Cell Biol; 1999 Mar; 19(3):1981-9. PubMed ID: 10022885
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mimosine arrests cells in G1 by enhancing the levels of p27(Kip1).
    Wang G; Miskimins R; Miskimins WK
    Exp Cell Res; 2000 Jan; 254(1):64-71. PubMed ID: 10623466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.